InsidersTradesSigma
Total declarations
Company
▲ Purchases (7 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by TIDMARSH GEORGE F, Director. Officer active across 1 company, notably Revelation Biosciences, INC.. Cumulatively, 7 reports have been recorded. Breakdown: 7 buys · 0 sell. Total volume traded: €97k. Activity tracked since 4 February 2022. The latest transaction was filed on 25 February 2022 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
20,000 shares@ US$1.600.75% mcap29.5% of flowCommon StockSEC:0001209191-22-013741:0
Ideal exit: 22 Nov 2022 (T+270)
1,000 shares@ US$2.540.058% mcap2.3% of flowCommon StockSEC:0001209191-22-008580:0
Ideal exit: 5 Nov 2022 (T+270)
1,000 shares@ US$2.546.5% of flowCommon StockSEC:0001209191-22-008580
Ideal exit: 5 Nov 2022 (T+270)
7,900 shares@ US$2.31090.42% mcap16.5% of flowCommon StockSEC:0001209191-22-008025:0
Ideal exit: 1 Nov 2022 (T+270)
7,900 shares@ US$2.310946.7% of flowCommon StockSEC:0001209191-22-008025
Ideal exit: 1 Nov 2022 (T+270)
7,900 shares@ US$2.31090.42% mcap16.5% of flowCommon StockSEC:0001209191-22-007837:0
Ideal exit: 1 Nov 2022 (T+270)
7,900 shares@ US$2.310946.7% of flowCommon StockSEC:0001209191-22-007837
Ideal exit: 1 Nov 2022 (T+270)
7 of 7 declarations
About TIDMARSH GEORGE F
George F. Tidmarsh is a Board Member of REVELATION BIOSCIENCES, INC. In this role, he participates in the governance of the company and strategic decision-making. His experience and skills provide valuable insights to board discussions. As a board member, he ensures that stakeholder interests are considered.
